GENE ONLINE|News &
Analysis of the Patent Industry for Treating Erectile Dysfunction (ED)
According to the epidemiological data, the prevalence of erectile dysfunction is estimated to be between 14% and 48%. In addition, due to male privacy and conservatism, the prevalence may be underestimated. In fact, the incidence of moderate to severe ED is 9% among men aged 40-44, while it exceeds 56% in men aged 65 and above.
This article aims to provide a brief analysis of the related patents for the common active pharmaceutical ingredient Sildenafil in the treatment of Erectile dysfunction.
This article aims to provide a brief analysis of the related patents for the common active pharmaceutical ingredient Sildenafil in the treatment of Erectile dysfunction.
It's free! Log in now to read
LATEST
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
